The Lanka Hospitals Corporation PLC (COSE:LHCL.N0000)
Sri Lanka flag Sri Lanka · Delayed Price · Currency is LKR
0.00
0.00 (0.00%)
Price not available due to exchange restrictions

COSE:LHCL.N0000 Income Statement

Millions LKR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
13,93213,65012,41910,69810,0346,804
Revenue Growth (YoY)
2.27%9.92%16.09%6.62%47.47%-9.87%
Cost of Revenue
7,7887,7007,2106,2605,2703,942
Gross Profit
6,1445,9515,2094,4384,7642,862
Selling, General & Admin
3,2613,0732,8242,3892,2902,024
Other Operating Expenses
1,1091,1401,187845.68623.43639.19
Operating Expenses
4,3714,2144,0113,2352,9142,663
Operating Income
1,7741,7371,1981,2031,850198.7
Interest Expense
-56.03-57.94-33.03-30.38-32.6-34.92
Interest & Investment Income
621.06678.051,258927.52252.32198.16
Currency Exchange Gain (Loss)
82.9-433.88-518.041,955153.9551.38
Other Non Operating Income (Expenses)
00-000-
EBT Excluding Unusual Items
2,4211,9231,9044,0552,224413.33
Gain (Loss) on Sale of Assets
-27.73-27.735.835.89.04-2.97
Pretax Income
2,3941,8951,9104,0612,233410.36
Income Tax Expense
718.11555.89564.76814.3421.1225.37
Net Income
1,6761,3391,3453,2472,212384.99
Net Income to Common
1,6761,3391,3453,2472,212384.99
Net Income Growth
12.97%-0.43%-58.57%46.82%474.43%-33.70%
Shares Outstanding (Basic)
224224224224224224
Shares Outstanding (Diluted)
224224224224224224
EPS (Basic)
7.495.996.0114.519.881.72
EPS (Diluted)
7.495.996.0114.519.881.72
EPS Growth
13.15%-0.39%-58.58%46.86%474.16%-33.70%
Free Cash Flow
1,452598.16663.43343.31,710205.55
Free Cash Flow Per Share
6.492.672.961.537.640.92
Dividend Per Share
3.5001.500-3.5002.750-
Dividend Growth
---27.27%--
Gross Margin
44.10%43.59%41.95%41.48%47.48%42.07%
Operating Margin
12.73%12.72%9.64%11.25%18.44%2.92%
Profit Margin
12.03%9.81%10.83%30.35%22.04%5.66%
Free Cash Flow Margin
10.42%4.38%5.34%3.21%17.04%3.02%
EBITDA
2,4852,3651,7551,6642,308632.62
EBITDA Margin
17.84%17.33%14.13%15.55%23.00%9.30%
D&A For EBITDA
711.47628.44557.33460.63458.1433.92
EBIT
1,7741,7371,1981,2031,850198.7
EBIT Margin
12.73%12.72%9.64%11.25%18.44%2.92%
Effective Tax Rate
30.00%29.33%29.57%20.05%0.95%6.18%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.